Diversion control

Each opioid treatment program shall develop: 1. A diversion control plan that demonstrates accountability to its patients and to the community. The diversion control plan should reflect the efficient use of personnel and other resources to achieve the highest quality of patient care, while reducing possibilities for diversion of controlled substances from legitimate treatment to illicit use. 2. Each opioid treatment program shall inform its patients that diversion will be reported to law enforcement and the division and shall indicate how suspicions or evidence of diversion will be handled clinically. Each opioid treatment program shall establish clinical procedures to minimize diversion risk to ensure appropriate treatment, such as: a. Routine toxicology screens; b. Pill call backs for counting; c. Bubble packing of prescriptions; and d. Making copies of the identification numbers listed on the "strip" packaging to be available for call backs. 3. Each opioid treatment program shall: a. Provide regular and continuous staff education. b. Review program policies and procedures at least annually. c. Adhere to universal or standard infection control precautions promulgated by the centers for disease control and prevention.